Rajesh Chawla

Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries

Vincenzo Russotto, Sheila Nainan Myatra, John G. Laffey et al. · JAMA · 2021 · 619 citations · Full text

Medicine, Emergency Medicine, Critical Care Anesthesiology +12

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

Lene Russell, Kis Rønn Uhre, Ann Louise Syraach Lindgaard et al. · JAMA · 2021 · 263 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Arvinder S. Soin, Kuldeep Kumar, Narendra S. Choudhary et al. · The Lancet Respiratory Medicine · 2021 · 237 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module

Víctor Rosenthal, Ider Bat-Erdene, Debkishore Gupta et al. · American Journal of Infection Control · 2019 · 189 citations

Public Health, Infectious Disease Control, Infectious Diseases +16

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Anders Granholm, Marie Warrer Munch, Sheila Nainan Myatra et al. · Intensive Care Medicine · 2021 · 122 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17